Skip to main content
. 2021 Nov 1;46:20–26. doi: 10.1016/j.athplu.2021.10.002

Table 2.

Odds ratio and 95% confidence interval for the association between remnant cholesterol and atherosclerosis.

Outcomes Remnant cholesterol, mmol/L
P for trend
Q1 (<0.22) Q2 (0.22–0.50) Q3 (0.50–1.01) Q4 (≥1.01) Per 1 mmol/L increase
ICAS
 Unadjusted Reference 1.13(0.86–1.50) 1.21(0.92–1.60) 1.82(1.41–2.36) 1.28(1.15–1.42) <0.0001
 Adjusted Reference 1.04(0.77–1.40) 1.08(0.81–1.46) 1.61(1.21–2.15) 1.23(1.10–1.38) <0.0001
Carotid plaque
 Unadjusted Reference 1.11(0.92–1.33) 1.66(1.38–2.00) 2.07(1.71–2.50) 1.32(1.21–1.43) 0.0695
 Adjusted Reference 0.93(0.75–1.16) 1.30(1.04–1.62) 1.60(1.27–2.01) 1.14(1.02–1.26) <0.0001
CAS
 Unadjusted Reference 1.06(0.89–1.28) 1.60(1.33–1.92) 1.97(1.63–2.37) 1.31(1.20–1.42) 0.0295
 Adjusted Reference 0.88(0.71–1.09) 1.24(1.00–1.54) 1.51(1.21–1.90) 1.14(1.04–1.26) <0.0001
Carotid hypertrophy
 Unadjusted Reference 1.02(0.83–1.26) 1.67(1.37–2.05) 2.34(1.92–2.85) 1.47(1.34–1.60) <0.0001
 Adjusted Reference 0.79(0.60–1.04) 1.12(0.86–1.46) 1.73(1.33–2.25) 1.30(1.16–1.44) <0.0001

Abbreviations: CAS, carotid artery stenosis; ICAS, intracranial arterial stenosis.

Adjusted for age and sex, body mass index, systolic blood pressure, diastolic blood pressure, education, income, smoking status, drinking status, physical activity, a history of hypertension, diabetes mellitus, and dyslipidemia, antihypertensive agents, antidiabetic agents, lipid-lowering agents, fasting blood glucose, total cholesterol, high-density lipoprotein cholesterol, and high sensitivity C-reactive protein.